Di Filippo S, Bozio A, Sassolas F, Champsaur G, Ninet J
Service de cardiologie C, hôpital cardiovasculaire et pneumologique Louis-Pradél, Lyon.
Arch Mal Coeur Vaiss. 1997 May;90(5):617-23.
Between December 1984 and September 1996, 43 cardiac transplantations were carried out in 40 patients aged 2 days to 21 years (one third under 10 years of age) for cardiomyopathy (21 cases), congenital heart disease (19 cases) or retransplantation (3 cases). The average waiting time for transplantation was 80 days: this delay increased by a factor of five in 2 years (from 1 month, before 1994, to 5 months at present). Twelve patients dies, including 6 before the 8th day. The 28 survivors were prescribed triple immunosuppressive therapy: the average follow-up was 4.4 years (range 3 months to 11 years). Monitoring rejection was carried out by non-invasive methods based on clinical, electrocardiographic and Doppler echocardiographic observations. Any suspicion of acute rejection led to endomyocardial biopsy for confirmation and therapeutic guidance. There was a total of 47 episodes of acute rejection (0.3 per patient), mainly in the first 3 months: acute rejection was less common in the younger children. Graft function was normal in 71% of cases. Five children have a pacemaker implanted during the first month. Despite continuous steroid therapy, 82% of patients had normal staturo-ponderal growth. The myocardial mass of the graft increased in parallel with the body surface area. Nephrotoxicity of ciclosparine was responsible for significant renal failure in 19% of patient and seemed more common in the young children. Psychological disturbances were commonest in adolescence and could result in poor treatment compliance (4 cases, with 1 death and 2 retransplantations). Despite satisfactory medium-term results, nephrotoxicity of ciclosporine, long-term graft function and psychological difficulties of adolescents remain unresolved so that transplantation is reserved for terminal cardiac disease resistant to all other forms of treatment.
1984年12月至1996年9月期间,对40例年龄在2天至21岁(三分之一年龄在10岁以下)的患者进行了43例心脏移植手术,病因包括心肌病(21例)、先天性心脏病(19例)或再次移植(3例)。移植的平均等待时间为80天:这一延迟在2年里增加了5倍(从1994年前的1个月增至目前的5个月)。12例患者死亡,其中6例在第8天前死亡。28例幸存者接受三联免疫抑制治疗:平均随访时间为4.4年(范围为3个月至11年)。通过基于临床、心电图和多普勒超声心动图观察的非侵入性方法监测排斥反应。任何急性排斥反应的可疑情况均导致进行心内膜心肌活检以确诊并指导治疗。共有47次急性排斥反应发作(每位患者0.3次),主要发生在前3个月:急性排斥反应在年幼儿童中较少见。71%的病例移植功能正常。5名儿童在第一个月内植入了起搏器。尽管持续使用类固醇治疗,但82%的患者身高体重增长正常。移植心脏的心肌质量与体表面积平行增加。环孢素的肾毒性导致19%的患者出现严重肾衰竭,且在年幼儿童中似乎更常见。心理障碍在青少年中最为常见,可能导致治疗依从性差(4例,1例死亡,2例再次移植)。尽管中期结果令人满意,但环孢素的肾毒性、移植心脏的长期功能以及青少年的心理问题仍未得到解决,因此心脏移植仅用于对所有其他治疗形式均耐药的终末期心脏病。